PortfoliosLab logo
TPL vs. CPRX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TPL and CPRX is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

TPL vs. CPRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Texas Pacific Land Corporation (TPL) and Catalyst Pharmaceuticals, Inc. (CPRX). The values are adjusted to include any dividend payments, if applicable.

0.00%5,000.00%10,000.00%15,000.00%20,000.00%NovemberDecember2025FebruaryMarchApril
14,831.59%
284.43%
TPL
CPRX

Key characteristics

Sharpe Ratio

TPL:

2.33

CPRX:

1.43

Sortino Ratio

TPL:

2.82

CPRX:

2.29

Omega Ratio

TPL:

1.42

CPRX:

1.26

Calmar Ratio

TPL:

3.51

CPRX:

1.96

Martin Ratio

TPL:

8.17

CPRX:

8.26

Ulcer Index

TPL:

16.09%

CPRX:

7.17%

Daily Std Dev

TPL:

56.48%

CPRX:

41.42%

Max Drawdown

TPL:

-73.05%

CPRX:

-94.25%

Current Drawdown

TPL:

-22.69%

CPRX:

-8.90%

Fundamentals

Market Cap

TPL:

$30.70B

CPRX:

$2.86B

EPS

TPL:

$19.75

CPRX:

$1.31

PE Ratio

TPL:

67.58

CPRX:

17.90

PEG Ratio

TPL:

0.00

CPRX:

0.00

PS Ratio

TPL:

43.50

CPRX:

5.82

PB Ratio

TPL:

27.09

CPRX:

3.89

Total Revenue (TTM)

TPL:

$531.68M

CPRX:

$393.23M

Gross Profit (TTM)

TPL:

$480.63M

CPRX:

$327.56M

EBITDA (TTM)

TPL:

$424.42M

CPRX:

$177.46M

Returns By Period

In the year-to-date period, TPL achieves a 20.81% return, which is significantly higher than CPRX's 12.36% return. Over the past 10 years, TPL has outperformed CPRX with an annualized return of 41.40%, while CPRX has yielded a comparatively lower 21.69% annualized return.


TPL

YTD

20.81%

1M

0.20%

6M

21.81%

1Y

128.39%

5Y*

53.34%

10Y*

41.40%

CPRX

YTD

12.36%

1M

-5.60%

6M

9.27%

1Y

57.49%

5Y*

36.91%

10Y*

21.69%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TPL vs. CPRX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TPL
The Risk-Adjusted Performance Rank of TPL is 9595
Overall Rank
The Sharpe Ratio Rank of TPL is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of TPL is 9494
Sortino Ratio Rank
The Omega Ratio Rank of TPL is 9494
Omega Ratio Rank
The Calmar Ratio Rank of TPL is 9898
Calmar Ratio Rank
The Martin Ratio Rank of TPL is 9393
Martin Ratio Rank

CPRX
The Risk-Adjusted Performance Rank of CPRX is 9090
Overall Rank
The Sharpe Ratio Rank of CPRX is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of CPRX is 9090
Sortino Ratio Rank
The Omega Ratio Rank of CPRX is 8585
Omega Ratio Rank
The Calmar Ratio Rank of CPRX is 9393
Calmar Ratio Rank
The Martin Ratio Rank of CPRX is 9393
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TPL vs. CPRX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Texas Pacific Land Corporation (TPL) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for TPL, currently valued at 2.33, compared to the broader market-2.00-1.000.001.002.003.00
TPL: 2.33
CPRX: 1.43
The chart of Sortino ratio for TPL, currently valued at 2.82, compared to the broader market-6.00-4.00-2.000.002.004.00
TPL: 2.82
CPRX: 2.29
The chart of Omega ratio for TPL, currently valued at 1.42, compared to the broader market0.501.001.502.00
TPL: 1.42
CPRX: 1.26
The chart of Calmar ratio for TPL, currently valued at 3.51, compared to the broader market0.001.002.003.004.005.00
TPL: 3.51
CPRX: 1.96
The chart of Martin ratio for TPL, currently valued at 8.17, compared to the broader market-5.000.005.0010.0015.0020.00
TPL: 8.17
CPRX: 8.26

The current TPL Sharpe Ratio is 2.33, which is higher than the CPRX Sharpe Ratio of 1.43. The chart below compares the historical Sharpe Ratios of TPL and CPRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00NovemberDecember2025FebruaryMarchApril
2.33
1.43
TPL
CPRX

Dividends

TPL vs. CPRX - Dividend Comparison

TPL's dividend yield for the trailing twelve months is around 1.16%, while CPRX has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
TPL
Texas Pacific Land Corporation
1.16%1.58%0.83%1.37%0.88%3.58%0.77%0.75%0.30%0.10%0.22%0.23%
CPRX
Catalyst Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

TPL vs. CPRX - Drawdown Comparison

The maximum TPL drawdown since its inception was -73.05%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for TPL and CPRX. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-22.69%
-8.90%
TPL
CPRX

Volatility

TPL vs. CPRX - Volatility Comparison

Texas Pacific Land Corporation (TPL) has a higher volatility of 26.23% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 14.53%. This indicates that TPL's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%NovemberDecember2025FebruaryMarchApril
26.23%
14.53%
TPL
CPRX

Financials

TPL vs. CPRX - Financials Comparison

This section allows you to compare key financial metrics between Texas Pacific Land Corporation and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items